SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
255 hedge funds and large institutions have $2.88B invested in Sage Therapeutics in 2021 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 100 increasing their positions, 73 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
28% less capital invested
Capital invested by funds: $3.97B → $2.88B (-$1.1B)
53% less call options, than puts
Call options by funds: $58.6M | Put options by funds: $125M
Holders
255
Holding in Top 10
5
Calls
$58.6M
Puts
$125M
Top Buyers
| 1 | +$36.7M | |
| 2 | +$34.9M | |
| 3 | +$31.4M | |
| 4 |
DKCM
Davidson Kempner Capital Management
New York
|
+$21M |
| 5 |
AG
Artal Group
Luxembourg
|
+$19.9M |
Top Sellers
| 1 | -$108M | |
| 2 | -$52.9M | |
| 3 | -$49.1M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$47.5M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$38.7M |